These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7585208)

  • 41. GalCer, CD26 and HIV infection of intestinal epithelial cells.
    Fantini J; Yahi N; Delezay O; Gonzalez-Scarano F
    AIDS; 1994 Sep; 8(9):1347-8. PubMed ID: 7802993
    [No Abstract]   [Full Text] [Related]  

  • 42. The CD4 receptor for the AIDS virus.
    Weiss RA; Clapham PR; McClure M; Marsh M
    Biochem Soc Trans; 1989 Aug; 17(4):644-7. PubMed ID: 2475372
    [No Abstract]   [Full Text] [Related]  

  • 43. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ultrastructural analysis of morphogenesis of immunodeficiency viruses].
    Nakai M; Goto T
    Uirusu; 1991 Jun; 41(1):1-9. PubMed ID: 1810086
    [No Abstract]   [Full Text] [Related]  

  • 45. Skepticism greets HIV coreceptor.
    Balter M
    Science; 1993 Nov; 262(5135):843-4. PubMed ID: 7901911
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions of HIV gp120 with the CD4 molecule on lymphocytes and in the nervous system.
    Sattentau QJ
    Ann N Y Acad Sci; 1990; 594():355-61. PubMed ID: 2198840
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Traunecker A; Lüke W; Karjalainen K
    Nature; 1988 Jan; 331(6151):84-6. PubMed ID: 2829024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.
    Callebaut C; Krust B; Jacotot E; Hovanessian AG
    Science; 1993 Dec; 262(5142):2045-50. PubMed ID: 7903479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of tryptase TL2 and CD26 antigen in brain-derived cells non-permissive to T-cell line-tropic human immunodeficiency virus type 1.
    Shimizu N; Kobayashi M; Liu HY; Kido H; Hoshino H
    FEBS Lett; 1995 Jan; 358(1):48-52. PubMed ID: 7821428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.
    Pert CB; Hill JM; Ruff MR; Berman RM; Robey WG; Arthur LO; Ruscetti FW; Farrar WL
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9254-8. PubMed ID: 3097649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.
    Tamamura H; Ishihara T; Otaka A; Murakami T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochim Biophys Acta; 1996 Nov; 1298(1):37-44. PubMed ID: 8948487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.
    Kolesnitchenko V; Wahl LM; Tian H; Sunila I; Tani Y; Hartmann DP; Cossman J; Raffeld M; Orenstein J; Samelson LE; Cohen DI
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11889-93. PubMed ID: 8524869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A second coreceptor for HIV in early stages of infection.
    Balter M
    Science; 1996 Jun; 272(5269):1740. PubMed ID: 8650568
    [No Abstract]   [Full Text] [Related]  

  • 58. A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4.
    Hewson TJ; Logie JJ; Simmonds P; Howie SE
    J Immunol; 2001 Apr; 166(8):4835-42. PubMed ID: 11290759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.
    Moulard M; Lortat-Jacob H; Mondor I; Roca G; Wyatt R; Sodroski J; Zhao L; Olson W; Kwong PD; Sattentau QJ
    J Virol; 2000 Feb; 74(4):1948-60. PubMed ID: 10644368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. V3-mediated heparin neutralization of HIV type 1.
    Javaherian K; Khiroya R; Quinlan C; Boyd JG; Hanham KA
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1421-3. PubMed ID: 7888195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.